Safety and Efficacy of TKI258 in Relapsed or Refractory Multiple Myeloma Patients, Who Are With or Without t(4;14) Chromosomal Translocation
Clinical trial NCT01058434 · COMPLETED
Trial details
- NCT number
- NCT01058434
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2010-05-01
- Primary completion
- 2013-02-01
- Enrollment
- 43
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.